Lidocaine 5% Gel
RxNorm 1010057· LIDOCAINE HCL 5%· TOPICAL
Puretek Corporation
Indications and usage
INDICATIONS: For the temporary relief of pain.
Dosage and administration
DOSAGE: Adults and children 12 years of age and older: apply a thin film to the affected areas(s) two or three times per day or as directed by a licensed healthcare practitioner.
Warnings
WARNINGS: For external use only. Not for ophthalmic use.
PRECAUTIONS: If irritation or sensitivity occurs or infection appears, discontinue use and institute appropriate therapy. Lidocaine 5% Gel should be used with caution in ill, elderly, debilitated patients and children who may be more sensitive to the systemic effects of lidocaine.
Contraindications
CONTRAINDICATIONS: Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
Pregnancy
Use in Pregnancy: Teratogenic Effects; Pregnancy Category B. Reproduction studies have been performed for lidocaine in rats at doses up to 6.6 times the human dose and have revealed no evidence of harm to the fetus caused by lidocaine. There are, however, no adequate and well-controlled studies in pregnant women. Animal reproduction studies are not always predictive of human response. General consideration should be given to this fact before administering lidocaine to women of childbearing potential, especially during early pregnancy when maximum organogenesis takes place.
Nursing mothers
Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this drug is administered to a nursing mother.
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- injection site pain5
- injection site erythema3
- product quality issue3
- eschar2
- injection site induration2
- blood creatinine increased1
- drug ineffective1
- injection site pruritus1
- injection site vesicles1
- neoplasm progression1
- off label use1
- product use issue1
- renal impairment1
Adverse reactions (label)
ADVERSE REACTIONS: During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.
View more: Full FDA label on DailyMed →Label effective 20250919